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Abstract 
Background: Orofacial inflammatory pain is likely to accompany referred pain in uninflamed orofacial structures. 
The ectopic pain precludes precise diagnosis and makes treatment problematic, because the underlying mechanism 
is not well understood. Using the established ectopic orofacial pain model induced by complete Freund’s adjuvant 
(CFA) injection into trapezius muscle, we analyzed the possible role of p38 phosphorylation in activated microglia in 
ectopic orofacial pain.
Results: Mechanical allodynia in the lateral facial skin was induced following trapezius muscle inflammation, which 
accompanied microglial activation with p38 phosphorylation and hyperexcitability of wide dynamic range (WDR) 
neurons in the trigeminal spinal subnucleus caudalis (Vc). Intra-cisterna successive administration of a p38 mitogen-
activated protein kinase selective inhibitor, SB203580, suppressed microglial activation and its phosphorylation of 
p38. Moreover, SB203580 administration completely suppressed mechanical allodynia in the lateral facial skin and 
enhanced WDR neuronal excitability in Vc. Microglial interleukin-1β over-expression in Vc was induced by trapezius 
muscle inflammation, which was significantly suppressed by SB203580 administration.
Conclusions: These findings indicate that microglia, activated via p38 phosphorylation, play a pivotal role in WDR 
neuronal hyperexcitability, which accounts for the mechanical hypersensitivity in the lateral facial skin associated with 
trapezius muscle inflammation.
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Background
Referred pain originating from the trapezius muscle fre-
quently produces orofacial pathological pain such as 
tension-type headaches or temporomandibular disorder 
(TMD) [1, 2]. Clinically, orofacial pain is likely to occur 
in areas far away from the trapezius muscle, which causes 
misdiagnosis and/or inappropriate treatment [3]. In ani-
mal experiments, it has been shown that masseter muscle 
injection of exogenous substances such as glutamate or 
nerve growth factor produces nociceptive disturbances in 
discrete areas similar to those reported in TMD patients 
[4–6]. Nevertheless, the mechanisms underlying nocic-
eptive disturbances in discrete areas associated with such 
muscle inflammation are still poorly understood.
The mitogen-activated protein kinases (MAPKs), 
which belong to a highly conserved family of serine/
threonine protein kinases, are involved in various cell 
signaling and gene expression in central nervous system 
(CNS) [7]. A variety of extracellular stimuli activate intra-
cellular MAPKs by phosphorylation, which modulates 
intracellular responses driving different downstream 
signaling [8]. p38, which is a member of a MAPK fam-
ily, is present constitutively in non-neuronal glial cells 
in the spinal cord, and is phosphorylated via proinflam-
matory cytokines released in the spinal cord associated 
with peripheral inflammation, and is thought to play an 
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essential role in inflammatory pain [9, 10]. Among non-
neuronal glial cells in the CNS, microglia, which oper-
ates as resident macrophages, are capable of activation 
following peripheral inflammation. Activated microglia 
exhibit a morphological change from a ramified shape 
to an amoeboid shape and an increase in proliferation, 
which can be defined immunohistochemically using ion-
ized calcium-binding adaptor molecule-1 (Iba1) antibody 
[11, 12]. By extension, it has been reported that such 
morphological changes in microglia is caused via the p38 
signaling cascades [13, 14]. After microglial activation 
(phosphorylation), p38 phosphorylation is likely to pro-
mote the synthesis of several downstream molecules such 
as cyclooxygenase-2 or interleukin (IL)-1β in activated 
microglia via transcriptional regulation [15, 16]. Accord-
ingly, the microglial activation is presumably involved in 
the generation of central sensitization via production of 
proinflammatory cytokines, thus contributing to patho-
logical pain.
In this study, we demonstrated the possible role of p38 
phosphorylation in activated microglia in ectopic oro-
facial pain associated with trapezius muscle inflamma-
tion using the ectopic orofacial pain model established 
by complete Freund’s adjuvant (CFA) injection into tra-
pezius muscle [17]. We examined changes in the Iba1 
immunoreactivity in trigeminal spinal subnucleus cau-
dalis (Vc). We also considered whether p38 in activated 
microglia was phosphorylated and whether the inhibition 
of p38 phosphorylation in microglia depressed mechani-
cal hypersensitivity in facial skin. Moreover, we exam-
ined the changes in wide dynamic range (WDR) neuronal 
excitability due to the inhibition of p38 phosphorylation 
in microglia following trapezius muscle inflammation.
Results
Changes in mechanical sensitivity following CFA injection
HWT to mechanical stimulation of the lateral facial 
skin significantly decreased on day 4 after CFA injection 
into the trapezius muscle (13.7 ±  3.7  g) compared with 
saline-injected rats (28.9 ± 3.5 g) (p < 0.05) (Fig. 1). No 
significant changes in HWT to mechanical stimulation 
of the contralateral lateral facial skin in the CFA-injected 
rats were observed compared with naive rats (data not 
shown). Body weight over the course of the experiment 
was not significantly different between saline-injected 
and CFA-injected rats.
Microglial activation in Vc
Microglia in Vc showed Iba1 immunoreactivity which 
had a large soma with thick processes on day 4 after 
CFA injection into the trapezius muscle compared with 
that of the saline group (Fig.  2a–c). On day 15 after 
CFA injection, microglia in Vc had no large soma with 
thick processes (Fig. 2d). The density of Iba1-IR cells on 
day 4 after CFA injection was much larger than that of 
saline in Vc at 1,440, 2,160 or 2,880  μm caudal to the 
obex (−1,440 μm, CFA: 8.7 ± 0.6 %, saline: 5.9 ± 0.5 %; 
−2,160  μm, CFA: 9.5  ±  0.8  %, saline; 6.2  ±  0.7  %, 
−2,880  μm, CFA; 11.4  ±  1.2  %, saline: 7.6  ±  0.8  %) 
(Fig. 2e). On day 15, there were no significant differences 
in the density of Iba1-IR cells at 1,440, 2,160 or 2,880 μm 
caudal to the obex between CFA-injected and saline-
injected rats.
p38 phosphorylation in activated microglia in Vc
The p38 phosphorylation in Vc was examined on day 4 
after CFA or saline injection into the trapezius muscle. 
Iba1-IR cells showed pp38 immunoreactivity in Vc but 
not in GFAP-IR or NeuN-IR cells (Fig. 3a–i). Moreover, 
changes in pp38 protein expression in Vc on day 4 after 
CFA or saline injection were also examined. The normal-
ized protein amount of pp38 in Vc ipsilateral to the CFA 
injection (2.4 ± 0.3) was significantly greater than that of 
saline injection (1.0 ± 0.1) (Fig. 3j).
Effect of i.c.m. SB203580 on mechanical sensitivity 
and microglial activation
The normalized protein amount of pp38 in Vc was sig-
nificantly increased on day 4 following CFA injection 
with i.c.m. vehicle administration compared with saline-
injected rats with i.c.m. vehicle administration, and this 
increase was completely abolished by successive i.c.m. 
SB203580 administration (day 0 through day 4) (Fig. 4a). 
The decrease of HWT on day 4 after CFA injection was 
also completely abolished by continuous i.c.m. SB203580 
administration from day 0 through day 4 (Saline with 
i.c.m. vehicle, 31.3  ±  3.7  g; CFA with i.c.m. vehicle, 
11.3  ±  3.3  g; CFA with i.c.m. SB203580, 30.3  ±  3.6  g) 
Fig. 1 Changes in mechanical sensitivity following CFA injection 
into trapezius muscle. HWT measured in facial skin for 15 days after 
CFA or saline injection into the ipsilateral trapezius muscle. The inset 
indicates the stimulus site. *p < 0.05 compared with saline-injected 
rats. Data represent mean ± SEM. (n = 10 in each group; two-way 
ANOVA with repeated measures, followed by Bonferroni’s multiple-
comparison tests).
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Fig. 2 Microglial activation in Vc following CFA injection into trapezius muscle. a Photomicrograph of Iba1-IR cells in Vc on day 4 after the CFA 
injection. High-magnificated photomicrograph of Iba1-IR cells in Vc on day 4 after CFA (b) or saline (c) injection. d High-magnificated photogmicro-
graph of Iba1-IR cells in Vc on day 15 after CFA injection. Scale bar 500 μm (a); 100 μm (b–d). e Density of the Iba1 immuno-products in Vc (1,440, 
2,160 and 2,800 μm caudal to the obex) on day 4 and 15 after saline or CFA injection. Data represent mean ± SEM; n = 13–14 in each; *p < 0.05, 
**p < 0.01; compared to saline-injected rats by Student’s t tests.
Fig. 3 p38 phosphorylation in microglia in Vc. Photomicrographs of pp38-IR cells (a, d, g), Iba1-IR cells (b), pp38-IR and Iba1-IR cells (c), GFAP-IR cells 
(e), pp38-IR and GFAP-IR cells (f), NeuN-IR cells (h), and pp38-IR and NeuN-IR cells (i) in Vc on day 4 after CFA injection. The arrow denotes double-
IR cells. j Relative amount of pp38 protein in Vc on day 4 after CFA or saline injection. p38 protein was used as a loading control. Data represent 
mean ± SEM; n = 12 in each; ***p < 0.001; compared to saline-injected rats by Student’s t tests.
Page 4 of 11Kiyomoto et al. Mol Pain  (2015) 11:48 
(Fig. 4b). Body weight over the course of the experiment 
was not significantly different between saline-injected 
and CFA-injected rats.
On day 4, though Iba1-IR cells in Vc showed large 
soma with thick processes following CFA injection 
with i.c.m. vehicle administration, Iba1-IR cells showed 
no histological changes following CFA injection with 
i.c.m. SB203580 administration or saline injection with 
i.c.m. vehicle administration (Fig.  4c–e). Moreover, the 
increase in the density of Iba1-IR cells in Vc was signifi-
cantly suppressed by i.c.m. SB203850 administration in 
CFA-injected rats at 1,440, 2,160 and 2,880 μm caudal to 
the obex (Fig. 4f ).
Effect of i.c.m. SB203580 on IL‑1β release from microglia 
in Vc
On day 4 after CFA injection into the trapezius muscle, 
Iba1-IR cells showed IL-1β immunoreactivity in Vc, and 
several NeuN-IR cells also showed IL-1β immunoreactiv-
ity (Fig. 5a–i). The protein amount of IL-1β in Vc ipsilat-
eral to CFA injection was significantly greater than that 
of saline-injected rats, and the increase of IL-1β protein 
amount in Vc was completely abolished following i.c.m. 
SB203580 administration (Fig. 5j).
Effect of SB203580 on Vc WDR neuronal activity
On day 4, the activity of WDR neurons were recorded 
from the Vc in CFA- or saline-injected rats, and the 
effects of i.c.m. administration of SB203580 on WDR 
neuronal activity in CFA-injected rats were assessed. 
The activity of twenty-seven WDR neurons was recorded 
from Vc in CFA-injected rats with i.c.m. vehicle or 
SB203580 administration, and in saline-injected rats 
with i.c.m. vehicle administration. On day 4, we found 
no significant difference in the background activities 
after saline injection with i.c.m. vehicle administration, 
after CFA injection with i.c.m. vehicle administration or 
after CFA injection with i.c.m. SB203580 administration 
(Fig.  6a). Further, brush- and pinch-evoked responses 
in CFA-injected rats with i.c.m. vehicle administration 
were significantly larger than that of saline-injected rats 
with i.c.m. vehicle administration or CFA-injected rats 
with i.c.m. SB203580 administration (Fig.  6b). In CFA-
injected rats, i.c.m. SB203580 administration significantly 
suppressed noxious as well as non-noxious mechanical-
evoked responses of WDR neurons compared with the 
i.c.m. vehicle-administered group (Fig. 6c). All recorded 
WDR neurons were located in the superficial laminae of 
the Vc (data not shown).
Fig. 4 Mechanical sensitivity in facial skin and microglial activation in CFA-injected rats with i.c.m. SB203580 administration. a Relative amount of 
pp38 protein in Vc on day 4 in saline or CFA-injected rats with i.c.m. vehicle or SB203580 administration. p38 protein was used as loading control. 
Data represent mean ± SEM. n = 16–17 in each. *p < 0.05, **p < 0.01; by one-way ANOVA followed by Tukey’s multiple-comparison tests. b HWT 
measured in facial skin on day 4 after CFA or saline injection with i.c.m. vehicle or SB203580 administration. n = 9–10 in each. **p < 0.01; by one-way 
ANOVA followed by a Kruskal–Wallis tests. Photomicrograph of Iba1-IR cells on day 4 after CFA injection into the trapezius muscle with i.c.m. vehicle 
(c) or SB203580 (d) administration. e Photomicrograph of Iba1-IR cells on day 4 after saline injection into the trapezius muscle with i.c.m. vehicle 
administration. Scale bar 100 μm. f Density of Iba1 immuno-products in Vc on day 4 in CFA- or saline-injected rats with i.c.m. vehicle or SB203580 
administration. Data represent mean ± SEM. n = 9–10 in each. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; by one-way ANOVA followed by 
Tukey’s multiple-comparison tests.
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Discussion
Various inflammatory pain models in the orofacial region 
were developed by CFA injection into the temporoman-
dibular joint [18], the whisker pad skin [19], the parotid 
gland [20], the tongue [21] or capsaicin injection into the 
lateral facial skin [22]. These models were assessed with 
mechanical or heat sensitivity on the inflammatory locus. 
On the other hand, it is well known that the patients who 
suffered from dental pain induced by pulp inflammation 
sometimes complain about the referred pain in other 
orofacial structures that have no pathological changes, 
which can account for misdiagnosis or inappropriate 
treatment [23, 24]. Therefore, it was necessary to clarify 
the mechanisms underlying ectopic orofacial pain asso-
ciated with remote local inflammation by developing 
an appropriate animal model. In this study, mechanical 
allodynia in the lateral facial skin was induced and there 
were no pathological changes in the lateral facial skin on 
day 4 following trapezius muscle inflammation, indicat-
ing that mechanical allodynia in the orofacial region can 
be induced by local inflammation in an area remote from 
this region. Thus, the established orofacial ectopic pain 
model is likely to be especially useful in the clarification 
of the pathogenic mechanisms of orofacial ectopic pain 
[17].
Primary afferent neurons are hyperexcited due to 
peripheral inflammation including the orofacial region, 
Fig. 5 IL-1β protein in saline- or CFA-injected rats with i.c.m. vehicle or SB203580 administration. Photomicrographs of IL-1β-IR cells (a, d, g), Iba1-IR 
cells (b), IL-1β-IR and Iba1-IR cells (c), GFAP-IR cells (e), IL-1β-IR and GFAP-IR cells (f), NeuN-IR cells (h), and IL-1β-IR and NeuN-IR cells (i) in Vc on day 
4 after CFA injection. The arrow indicates double-IR cells. j Relative amount of IL-1β protein in Vc on day 4 after CFA or saline injection with i.c.m. 
vehicle or SB203580 administration. β-Actin protein was used as loading control. Data represent mean ± SEM. n = 13 in each. *p < 0.05, **p < 0.01; 
by one-way ANOVA followed by Tukey’s multiple-comparison tests.
Fig. 6 Mechanical-evoked responses of Vc neurons after CFA injec-
tion with i.c.m. SB203580 administration. a Background activities of 
WDR neurons. WDR neuronal responses to mechanical stimuli by 
brush, pinch stimuli (b) or von Frey filament (c) on day 4 after saline or 
CFA injection with i.c.m. vehicle or SB203580 administration (9 WDR 
neurons from 4 CFA-injected rats with i.c.m. vehicle administration, 9 
WDR neurons from 4 CFA-injected rats with i.c.m. SB203580 adminis-
tration, 9 WDR neurons from 3 saline-injected rats with i.c.m. vehicle 
administration). Data represent mean ± SEM. *p < 0.05, **p < 0.01, 
***p < 0.001, ****p < 0.0001; by one-way ANOVA followed by Tukey’s 
multiple-comparison tests or by two-way ANOVA with repeated 
measures followed by Tukey’s multiple-comparison tests.
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which also facilitate the release of various neurotrans-
mitters in parallel with neuromodulators. These include 
adenosine triphosphate (ATP), substance P, calcitonin 
gene-related peptide, or brain-derived neurotrophic fac-
tor from the central terminals of primary neuron, which 
in turn cause changes in the excitability of postsynaptic 
nociceptive neurons [25, 26]. In microglia, P2X receptor 
expression is restricted to the P2X4 and P2X7 receptor 
subtypes [27–29]. The extracellular application of ATP 
induces an intracellular Ca2+ elevation in microglia, the 
intracellular Ca2+ elevation which is induced by bind-
ing to intrinsic P2X7 receptors phosphorylates p38 [30, 
31]. p38 is phosphorylated in activated microglia labeled 
with CD11b or Iba-1, and activated microglia demon-
strates morphological changes e.g. hypertrophy or pro-
cess retraction/extension [32–34]. We observed obvious 
microglial activation in Vc which had a large soma with 
thick processes associated with trapezius muscle inflam-
mation, and p38 was phosphorylated in the activated 
microglia. Further, successive i.c.m. administration of 
SB203580 suppressed p38 phosphorylation in microglia 
and microglial activation in Vc. Our results suggest that 
microglial activation accompanied with morphological 
changes in Vc and C1-C2 is induced via p38 phosphoryl-
ation following trapezius muscle inflammation. Though 
p38 phosphorylation in microglia was potentially facili-
tated by ATP signaling via P2X7 receptor, further studies 
to determine upstream signals of p38 phosphorylation 
in microglia attributable to peripheral inflammation are 
needed.
In this study, it was confirmed that the successive 
i.c.m. administration of SB203580 completely abolished 
p38 phosphorylation in Vc following trapezius mus-
cle inflammation. The successive i.c.m. administration 
of SB203580 also completely depressed the mechanical 
allodynia in the lateral facial skin, and microglial acti-
vation in Vc following trapezius muscle inflammation. 
The mechanical-evoked responses of WDR neurons 
in Vc were significantly enhanced after trapezius mus-
cle inflammation, and the evoked responses showed 
an increase in their firings following an increase in 
mechanical stimulus intensity. The successive i.c.m. 
administration of SB203580 depressed the enhance-
ment of the mechanical-evoked responses. Further, the 
enhanced background activity, and brush- and pinch-
evoked responses in WDR neurons after trapezius mus-
cle inflammation were also suppressed by the successive 
i.c.m. administration of SB203580. Moreover, IL-1β was 
significantly over-expressed in microglia in Vc ipsilat-
eral to the inflamed trapezius muscle, and the successive 
i.c.m. administration of SB203580 completely depressed 
the IL-1β protein over-expression. It is well established 
that p38 phosphorylation in microglia accelerates the 
synthesis of proinflammatory cytokines such as TNF-α, 
IL-1β, and IL-6, and these cytokines are released in the 
medulla or spinal cord [16]. Together, these findings sug-
gest that microglial activation followed by trapezius mus-
cle inflammation is prerequisite for activation of IL-1β 
post-translational maturation, and plays a critical role for 
the induction of IL-1β-converting enzyme activity and 
IL-1β release.
Intrathecal administration of IL-1β induces both ther-
mal and mechanical hypersensitivity due to changes in 
spinal dorsal horn (SDH) neuronal responses to noxious 
stimuli [35, 36]. The IL-1 receptor type I (IL-1RI), which 
is known as a functional receptor of IL-1β, functions as 
the ligand binding subunit in the IL-1 receptor complex 
[37]. IL-1RI exists in SDH neurons localized in the super-
ficial layers of the SDH, which suggests that IL-1β signal-
ing in SDH neurons influence neuronal excitability [38]. 
Indeed, intrathecal IL-1β administration increases the 
wind-up activity of SDH neurons [39]. IL-1β signaling 
also increases in intracellular Ca2+ concentration in SDH 
neurons, resulting in facilitation of the excitatory neuro-
transmission in the SDH [40–42]. Moreover, intrathecal 
IL-1β administration inhibits both the frequency and the 
amplitude of spontaneous postsynaptic currents in SDH 
neurons, reducing both gamma-aminobutyric acid- and 
glycine-mediated currents, indicating that the increase of 
IL-1β is also capable of facilitating excitatory neurotrans-
mission by suppressing inhibitory neurotransmission 
[43]. Taken together, the results of this study suggest that 
the increased release of IL-1β from activated microglia 
via p38 phosphorylation enhances neuronal excitability 
in Vc WDR neurons, which are involved in mechanical 
allodynia in the lateral facial skin associated with trape-
zius muscle inflammation (Fig. 7).
Conclusion
WDR neuronal hyperexcitability in Vc is associated 
with an increase in IL-1β release from activated micro-
glia via p38 phosphorylation, which plays a key role in 
developing the mechanical allodynia in the lateral facial 
skin following trapezius muscle inflammation. Thus, p38 
phosphorylation in microglia may be a promising thera-




All experiments were performed on male Sprague–Daw-
ley rats (Japan SLC, Shizuoka, Japan) weighing 210–260 g 
(n = 230). All rats were kept under the climate-controlled 
room on a 12 h light/dark cycle (light on at 7:00, light off 
at 19:00) with food and water ad libitum, and individually 
housed in clear polycarbonate cages (length × width × h
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eight = 48 × 26.5 × 21 cm) containing wood shavings as 
bedding in a home cage. The number of rats used in this 
study was based on the minimum required for statistical 
analysis. In all experiments, the sequencing of surgery 
and testing was pseudo-randomized to control for any 
possible confounding effects of order of testing. All stud-
ies were conducted in strict accordance with the National 
Institutes of Health Guide for the Care and Use of Lab-
oratory Animals and the guidelines of the International 
Association for the Study of Pain [44] and approved by 
the local animals ethics committee in Nihon University.
Induction of inflammation in trapezius muscle
Initially, rats were deeply anesthetized with an intraperi-
toneal (i.p.) injection of sodium pentobarbital (50  mg/
kg; Schering Plough, Whitehouse Station, NJ) and were 
placed on a warm mat (37  °C). The incision of the neck 
skin was made using the scalpel. 50 % Complete Freund’s 
adjuvant (CFA; 90  μl, diluted in saline, Sigma-Aldrich, 
St. Louis, MO) or saline was injected into the trapezius 
muscle. The incised skin was sutured with 5–0 silk. After 
the surgery, benzyl penicillin potassium (20,000 units, 
Penicillin G potassium, Meiji Seika, Tokyo, Japan) was 
intramuscularly injected to prevent infection.
Changes in mechanical sensitivity of the facial skin
Rats were allowed to acclimate for 1 h prior to observa-
tion in behavioral testing room, and placed in individual 
observation chambers. Rats were trained in daily sessions 
for approximately 5 days to keep quietly protruding their 
snout for 10  min from a hole in its front wall [45]. The 
rats could escape freely from mechanical stimulation 
to the facial skin under this condition without physical 
restraints. To assess changes in the mechanical sensitivity 
of the lateral facial skin ipsilateral to CFA or saline injec-
tion, von Frey filaments (Touch Test Sensory Evaluator, 
North Coast Medical, Morgan Hill, CA) were applied to 
the lateral facial skin before and after CFA or saline injec-
tion into trapezius muscle for 15  days. On day 4 after 
CFA injection into the trapezius muscle with i.c.m. con-
tinuous administration of SB203580, the mechanical sen-
sitivity of facial skin was defined as described above. The 
filament was applied at 1 s intervals for each stimulation, 
and the head-withdrawal threshold (HWT) was defined 
as the lowest force required to elicit a head-withdrawal 
reflex more than 3 of 5 stimulations. All behavioral test-
ings were conducted under blind conditions.
Iba1 immunoreactivity in Vc
The rats were anesthetized with sodium pentobarbital 
(50  mg/kg, i.p.) and transcardially perfused with saline 
followed by a fixative containing 4  % paraformaldehyde 
(PFA) in 0.1 M phosphate buffer (PB; pH = 7.4) on days 
4 and 15 after CFA or saline injection into the trapezius 
muscle. Then, the medulla was dissected out and fixed in 
4 % PFA for 1 day at 4 °C, and after that kept in 0.01 M 
phosphate buffer saline (PBS) containing 20  % sucrose 
for overnight for cryoprotection. Thirty micrometer 
thick tissue sections were cut from the medulla using 
a freezing microtome (Leica, Tokyo, Japan), and every 
sixth sections were collected in 0.01 M PBS. After rins-
ing the free-floating tissue sections in 0.01  M PBS, the 
sections were incubated in rabbit polyclonal Iba1 anti-
body (1:2,000, Wako, Osaka, Japan) to define activated 
microglial cells, for 72 h at 4  °C following incubating in 
10 % normal goat serum (NGS) in PBS for 1.5 h at room 
temperature (RT). Then, the sections were incubated in 
biotinylated goat anti-rabbit IgG (1:600, Vector Labora-
tories, Burlingame, CA, USA) for 2  h at RT. After rins-
ing with 0.01  M PBS, the sections were incubated in 
peroxidase-conjugated avidin–biotin complex (1:100, 
Vector Laboratories, Burlingame, CA) for 1  h at RT. 
After washing in 0.05 M Tris buffer (TB, pH 7.4), the sec-
tions were incubated in 0.035  % 3,3′-daiminobenzidine 
Fig. 7 Schematic presentation of contribution of p38 phosphoryla-
tion in medullary microglia to ectopic orofacial inflammatory pain. 
Microglia in medulla and upper cervical spinal cord was activated 
following trapezius muscle inflammation. IL-1β release from the 
activated microglia in trigeminal spinal subnucleus caudalis (Vc) 
was accelerated through p38 phosphorylation and the excitability 
of wide dynamic range (WDR) neurons in Vc was enhanced via IL-1β 
signaling. The enhancement of excitability of WDR neurons in Vc after 
trapezius muscle inflammation may result in ectopic mechanical 
allodynia in orofacial region.
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tetrahydrochloride hydrate (DAB, Sigma-Aldrich, St. 
Louis, MO), 0.2 % nickel ammonium sulfate, and 0.05 % 
peroxide in 0.05 M TB for about 5 min. After washing in 
PBS, the sections were serially mounted on MAS-coated 
Superfrost Plus microscope slides (Matsunami, Osaka, 
Japan), dehydrated in a series of ethanol (from 50 to 
100 %), and coverslipped.
Iba1 expression was analyzed in a square grid 
(26.7  ×  26.7  μm2) of Vc (1,440, 2,160 and 2,800  μm 
caudal to the obex) that receives afferents from the 
trigeminal nerve innervating the lateral facial skin. The 
area occupied by the Iba1 immuno-products was meas-
ured using a computer-assisted imaging analysis system 
(ImageJ 1.37v; NIH, Bethesda, MD).
Additionally, rats were deeply anesthetized with 
sodium pentobarbital (50 mg/kg, i.p.) and transcardially 
perfused with saline followed by a fixative containing 
4 % PFA in 0.1 M PB on day 4 after CFA injection into 
the trapezius muscle with i.c.m. continuous administra-
tion of SB203580. Then, the area occupied by the Iba1 
immuno-products in Vc was measured as described 
above after the medulla and upper cervical spinal cord 
were dissected out and fixed for 1  day at 4  °C and kept 
in 0.01 M PBS containing 20 % sucrose for overnight for 
cryoprotection.
We also performed immunohistochemical staining 
without primary antibody for Iba1 for three sections in 
each group of rats, and no immuno-products could be 
observed (data not shown).
Double‑labeling immunohistochemistry
Rats were anesthetized with sodium pentobarbital 
(50  mg/kg, i.p.) and transcardially perfused with saline 
followed by a fixative containing 4  % PFA in 0.1  M PB 
(pH 7.4) on day 4 after CFA or saline injection into the 
trapezius muscle. The medulla and upper cervical cord 
were kept in 0.01  M PBS containing 20  % sucrose for 
12 h for cryoprotection following dissection after perfu-
sion and immersed in the same fixative for 4  h at 4  °C. 
The medulla were embedded in TissueTek (Sakura Fine-
tek, Tokyo, Japan) and cut using a cryostat at a thickness 
of 10 μm. The medulla and upper cervical cord sections 
were thaw-mounted on MAS-coated Superfrost Plus 
microscope slides. Then, they were dried at RT in a dark 
room overnight. After rinsing with 0.01 M PBS, the sec-
tions were incubated with mouse monoclonal phos-
pho-p38 MAPK (Thr180/Tyr182) antibody (1:100, Cell 
Signaling) and rabbit polyclonal Iba1 antibody (1:1,000, 
Wako), rabbit polyclonal glial fibrillary acidic protein 
(GFAP) antibody (1:1,000, Dako) or rabbit polyclonal 
anti-neuronal nuclei (NeuN) antibody (1:100, Merck 
Millipore, Billerica, MA) in 0.01  M PBS containing 3  % 
NGS and 0.3 %Triton X-100 overnight at 4 °C to identify 
the localization of phospho-p38 MAPK in Vc. The sec-
tions were incubated with rabbit polyclonal anti-IL-1β 
antibody (1:100, Abcam, Cambridge, UK) and mouse 
monoclonal anti-Iba1 antibody (1:100, Abcam), mouse 
monoclonal anti-GFAP antibody (1:400, Merck Milli-
pore) or mouse monoclonal anti-NeuN antibody (1:100, 
Merck Millipore) in 0.01 M PBS containing 3 % NGS and 
0.3 % Triton X-100 overnight at 4 °C to identify the local-
ization of IL-1β in Vc. After rinsing with 0.01 M PBS, the 
sections were incubated in Alexa Fluor 488 anti-mouse 
IgG (1:100; Invitrogen) and Alexa Fluor 568 anti-rabbit 
IgG (1:100; Invitrogen) in 0.01 M PBS for 2 h at RT. Fol-
lowing rinsing with 0.01 M PBS, the sections were cover-
slipped in mounting medium (Thermo Fisher Scientific, 
Waltham, MA) and double immunoreactive (IR) cells 
were analyzed using a fluorescence microscope (Keyence, 
Osaka, Japan).
Western blotting analysis
The rats were anesthetized with sodium pentobarbital 
(50  mg/kg, i.p.) and perfused with saline on day 4 fol-
lowing CFA or saline injection into the trapezius mus-
cle. The medulla and upper cervical cord were excised 
and immediately homogenized in 100 μl of ice-cold lysis 
buffer (137  mM NaCl, 20  mM Tris–HCl, pH 8.0, 1  % 
NP40, 10  % glycerol, 1  mM phenylmethylsulfonyl fluo-
ride, 10 μg/ml aprotinin, 1 g/ml leupeptin, and 0.5 mM 
sodium vanadate) using a tube pestle (Thermo Fisher 
Scientific). Samples were centrifuged at 15,000  rpm for 
10 min at 4 °C and the supernatant was collected. Follow-
ing the protein concentration of the sample was deter-
mined with a protein assay kit (Bio-Rad, Hercules, CA, 
USA), the sample was heat-denatured in Laemmli sam-
ple buffer solution (Bio-Rad). The sample (30  μg) was 
subjected to electrophoresis for protein separation on 
10 % SDS-PAGE and electroblotted onto polyvinylidene 
difluoride membranes (Trans-Blot turbo Transfer pack, 
Bio-Rad) by using Trans-Blot Turbo (Bio-Rad). The mem-
brane was incubated overnight at 4 °C with phospho-p38 
(pp38) MAPK (Thr180/Tyr182) antibody (1:1,000, Cell 
Signaling) diluted in Tris-Buffered Saline and Tween 20 
(TBST) containing 5 % bovine serum albumin (BSA) fol-
lowing 3  % BSA (Bovogen, Essendon, Australia) incu-
bation. After incubation with horseradish peroxidase 
(HRP)-conjugated donkey anti-rabbit antibodies (Cell 
Signaling), each protein binding was visualized by using 
Western Lightning ELC Pro (PerikinElmer, Waltham, 
MA, USA). Band intensity was quantified using a Chemi-
Doc MP system (Bio-Rad). After removing protein bind-
ing on the membrane using a stripping reagent (Thermo 
Scientific), the band intensity was normalized to p38 
immunoreactivity on blots reproved with anti-p38 anti-
bodies (1:1,000, Cell Signaling).
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Furthermore, the rats were anesthetized with sodium 
pentobarbital (50 mg/kg, i.p.) and perfused with saline on 
day 4 after CFA injection into the trapezius muscle with 
i.c.m. continuous administration of SB203580. After the 
medulla and upper cervical spinal cord were excised and 
homogenized, the supernatant was collected. After that, 
the protein concentration of the sample was determined 
with a protein assay kit (Bio-Rad). The protein amounts 
of phospho-p38 (pp38) and IL-1β in the prepared sam-
ple were determined by the method described above (see 
“Western blotting analysis”) using pp38 MAPK (Thr180/
Tyr182) antibodies (1:1,000, Cell Signaling) or anti-IL-1β 
antibodies (1:1,000, Abcam) as primary antibodies, and 
HRP-conjugated donkey anti-rabbit antibodies (Cell 
Signaling) as secondary antibodies. In turn, the normali-
zation was performed using β-actin or p38 immunoreac-
tivity on blots reproved with anti-β-actin antibody (1:200, 
Santa Cruz, Santa Cruz, CA, USA) or anti-p38 antibody 
(1:1,000, Cell Signaling). The p38 and β-actin immunore-
activities were used as a loading control.
Inhibition of p38 phosphorylation in Vc
CFA or saline was injected into trapezius muscle under 
deep anesthesia with sodium pentobarbital (50  mg/kg, 
i.p.) and simultaneously placed in a stereotaxic frame. 
After each rat’s skull was exposed by midline skin inci-
sion, a small hole (diameter, 1 mm) was drilled above the 
location of the caudal part of the skull with a dental drill 
to insert a polyethylene tube (SP45; size: 0.5 × 0.8 mm; 
Natsume, Tokyo, Japan) into the cisterna magna [46]. A 
selective inhibitor of p38 MAPK, SB203580 (8 μmol/day, 
10  % dimethyl sulfoxide dissolved in saline, Cell Signal-
ing), was intra-cisterna magnally (i.c.m.) administrated 
for 4 successive days (day 0 through day 3) using a micro-
osmotic infusion pump (Model 2001; Alzet Durect, 
Cupertino, CA, USA) connected the polyethylene tube.
Vc neuronal recording
On day 4 after CFA or saline injection into the trapezius 
muscle in rats with i.c.m. continuous administration of 
SB203580 or vehicle, a single-neuron recording was per-
formed in Vc neurons using the procedures described 
previously [47]. The trachea and right femoral vein were 
cannulated to allow artificial respiration and intravenous 
administration of drugs under deep anesthesia using 
sodium pentobarbital (50  mg/kg, i.p.). The anesthesia 
was maintained with isoflurane (2–3 %) mixed with oxy-
gen during the experiment. The rat was placed in a stere-
otaxic frame, dura and pia mater were removed following 
laminectomy to expose brain surface. The rat was artifi-
cially ventilated with immobilization using pancuronium 
bromide (0.6  mg/kg, i.v.; Schering-Plough, Darmastadt, 
Germany). The electrocardiogram was monitored and the 
hearting rate was maintained at 250–300/min, End-tidal 
CO2 was maintained at 3.5–4.5  % and the rectal tem-
perature at 37 °C by a feedback-controlled heating blan-
ket (Nihon Koden, Tokyo, Japan). A pool was made with 
skin flaps around the laminectomy which was performed 
to expose Vc, and the brainstem kept wet with isotonic 
saline. A tungsten microelectrode (impedance = 13 MΩ, 
1000 Hz, FHC, St Bowdin, ME) was inserted into Vc to 
record single neuronal activity. Based on their responses 
to innocuous or noxious mechanical stimulation to the 
lateral facial skin, the recorded neurons were classi-
fied either as low-threshold mechanoreceptive neurons, 
WDR neurons or nociceptive-specific (NS) neurons, as 
previously described [48]. In this study, only WDR neu-
rons were analyzed. The activity of this single neuron was 
augmented using a differential amplifier (Nihon Koden) 
and stored in PC. Spike frequencies of stored single neu-
ronal activity were analyzed using the Spike II software 
(CED 1401, Cambridge, UK). Background activity was 
first recorded for 30  s before application of mechanical 
stimulation to the facial skin following identification of 
WDR neurons. For mechanical stimulation of the recep-
tive field, graded stimuli with von Frey filaments (1, 6, 15, 
26 and 60 g) and brushing with a nylon-hair brush were 
applied for 5  s at 10  s intervals. High-intensity stimula-
tion with pinch was produced by a small arterial clip. 
After neuronal recording, the recording sites in Vc were 
histologically identified as previously described [49].
Statistical analysis
Data were expressed as mean ±  SEM. Statistical analy-
ses were performed by Student’s t test, one-way ANOVA 
followed by Tukey’s multiple-comparison tests, Kruskal–
Wallis tests, two-way ANOVA followed by Bonferroni’s 
or Tukey’s multiple-comparison tests where appropriate. 
A value of p <0.05 was considered significant.
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